LXRX vs WST · rev $21.8M vs P/E 35, rev $1.72B
Lexicon Pharmaceuticals Inc (LXRX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
LXRX currently screens at market cap $327.2M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the LXRX and WST stock pages for the full models.
Not investment advice.